64 countries have approved the vaccine. These countries include Argentina, Iran, and India. The vaccine is currently being reviewed in the European Union by the European Medicines Agency.Sputnik V is a two-part adenovirus viral vector vaccine with an efficacy rate of 91.6%.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.Adenoviruses are a type of virus associated with the common cold and other illnesses.
They serve as the delivery vehicle for the DNA instructions to produce the spike protein of the SARS-CoV-2 virus in the body.